论文部分内容阅读
目的对参麦注射液辅助治疗小儿肺炎的临床治疗效果进行分析。方法随机抽取2008年至2011年期间小儿肺炎患者60例,随机分为两组,对照组和改良组,每组各30例患者。对对照组中的小儿肺炎患者及小宁常规的抗炎治疗,而对改良组中的小儿肺炎患者在常规的抗炎治疗的基础上加用参麦注射液。对两组患者的治疗效果进行比较分析。结果相对于对照组,改良组中患者的退热时间、胸片正常时间、住院时间以及止咳时间等均较短,并且出现并发心力衰竭现象明显更少,P<0.05。结论在对小儿肺炎患者进行治疗时,在常规的抗炎治疗基础上加用参麦注射液,对患者的疾病治疗有一定的积极临床意义,值得推广。
Objective To analyze the clinical effect of Shenmai injection in adjuvant treatment of pneumonia in children. Methods Sixty children with pneumonia from 2008 to 2011 were randomly selected and randomly divided into two groups: control group and modified group, with 30 patients in each group. The control group of children with pneumonia and Xiao-ning conventional anti-inflammatory treatment, and the improved group of children with pneumonia in the conventional anti-inflammatory treatment based on the use of Shenmai injection. The treatment effect of two groups of patients were compared. Results Compared with the control group, the patients in the modified group had shorter antipyretic time, shorter chest X-ray, shorter hospital stay and longer cough duration, and had significantly fewer concurrent heart failure (P <0.05). Conclusions In the treatment of children with pneumonia, adding Shenmai injection on the basis of conventional anti-inflammatory treatment has certain clinical significance for the treatment of patients with diseases, which is worthy of promotion.